Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0E6VR
|
|||
| Former ID |
DIB014797
|
|||
| Drug Name |
DS-1093
|
|||
| Indication | Anemia [ICD-11: 3A00-3A9Z; ICD-9: 280-285] | Phase 1 | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C5H10N2O2
|
|||
| Canonical SMILES |
C1CNC(CN1)C(=O)O
|
|||
| InChI |
1S/C5H10N2O2/c8-5(9)4-3-6-1-2-7-4/h4,6-7H,1-3H2,(H,8,9)
|
|||
| InChIKey |
JSSXHAMIXJGYCS-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 2762-32-5
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | HIF-prolyl hydroxylase (HPH) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02299661) Pilot PK/PD Study of DS-1093a in Patients With Chronic Kidney Disease. U.S. National Institutes of Health. | |||
| REF 2 | Company report (Daiichisankyo) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.